Meyka Pro banner
Pharvaris N.V.

Pharvaris N.V. (PHVS) Stock Overview

Explore Pharvaris N.V.’s financial performance, market position, analyst ratings, and future outlook.

PHVSNASDAQ
HealthcareBiotechnology
$33.97
$0.20(0.59%)
U.S. Market opens in 7h 25m

Pharvaris N.V. (PHVS)

Meyka AI Score

Z

Key Financials

Market Cap2.4B
P/E Ratio-10.64
EPS (TTM)$-3.19
ROE-0.67%
Fundamental Analysis

AI Price Forecasts

1 Month$36.67
3 Months$41.79
1 Year Target$28.09

PHVS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Pharvaris N.V. (NASDAQ: PHVS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Pharvaris N.V.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PHVS on the NASDAQ shows an RSI of 52.34, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $28.09 for the NASDAQ listing.

Key metrics behind Pharvaris N.V.'s NASDAQ-traded stock include a P/E ratio of -10.64 and a market capitalization of 2.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PHVS on the NASDAQ.

Price Performance (NASDAQ: PHVS)

1-Day Change
-0.59%
5-Day Change
-1.99%
1-Month Change
-0.12%
3-Month Change
18.32%
6-Month Change
24.94%
Year-to-Date (YTD) Change
22.41%
1-Year Change
69.85%
3-Year Change
102.68%
5-Year Change
136.72%
All-Time (Max) Change
17.14%

Contact Information

31 71 203 6410
Grafenauweg 8, Leiden, ZH, 6300

Company Facts

1,290 Employees
IPO DateFeb 4, 2021
CountryNL
Actively Trading

Frequently Asked Questions